Literature DB >> 12933873

SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis.

Oliver C Turner1, Robert G Keefe, Isamu Sugawara, Hiroyuki Yamada, Ian M Orme.   

Abstract

Inbred mice differ in their abilities to control the growth of Mycobacterium tuberculosis in the lung and can as a result be regarded as either resistant or susceptible strains. In this study we report that the SWR mouse is both highly susceptible and in addition appears incapable of establishing a characteristic state of chronic disease after low-dose aerosol infection. In comparison to C57BL/6 mice, SWR mice were unable to contain the bacterial load in the lungs, resulting in progressive fatal disease. Histologic analysis of the lung tissue revealed evidence of a florid inflammatory cell response in the SWR mice leading to degeneration and necrosis and consolidation of a large percentage of the lung surface area. Digestion of infected lungs and analysis by flow cytometry demonstrated an initially similar but eventually higher number of lymphocytes accumulating in the SWR mice. Additionally, in contrast to the C57BL/6 mice, SWR mice had a significantly lower percentage of CD4 T cells in the lungs showing evidence of proliferation and positive intracellular staining for gamma interferon during the first two months of infection, and a lower percentage of both CD4 and CD8T cells exhibiting differentiation to an effector/memory phenotype during the first month of infection. We propose that further investigation of the SWR mouse may provide a new animal model for immunocompetent individuals apparently unable to effectively control the growth of M. tuberculosis in the lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933873      PMCID: PMC187294          DOI: 10.1128/IAI.71.9.5266-5272.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis.

Authors:  J Turner; C D D'Souza; J E Pearl; P Marietta; M Noel; A A Frank; R Appelberg; I M Orme; A M Cooper
Journal:  Am J Respir Cell Mol Biol       Date:  2001-02       Impact factor: 6.914

2.  Identifying genetic susceptibility factors for tuberculosis in Africans: a combined approach using a candidate gene study and a genome-wide screen.

Authors:  R Bellamy
Journal:  Clin Sci (Lond)       Date:  2000-03       Impact factor: 6.124

Review 3.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  The latent tuberculosis bacillus (I'll let you know if I ever meet one).

Authors:  M Orme
Journal:  Int J Tuberc Lung Dis       Date:  2001-07       Impact factor: 2.373

Review 5.  Genetic susceptibility to mycobacteria and other infectious pathogens in humans.

Authors:  R Bellamy; A V Hill
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

6.  Immunological basis for reactivation of tuberculosis in mice.

Authors:  J Turner; M Gonzalez-Juarrero; B M Saunders; J V Brooks; P Marietta; D L Ellis; A A Frank; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung.

Authors:  C D D'Souza; A M Cooper; A A Frank; S Ehlers; J Turner; A Bendelac; I M Orme
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

8.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

9.  Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.

Authors:  M Gonzalez-Juarrero; O C Turner; J Turner; P Marietta; J V Brooks; I M Orme
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.

Authors:  I V Lyadova; E B Eruslanov; S V Khaidukov; V V Yeremeev; K B Majorov; A V Pichugin; B V Nikonenko; T K Kondratieva; A S Apt
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

View more
  15 in total

1.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

2.  CCL5 participates in early protection against Mycobacterium tuberculosis.

Authors:  Bridget Vesosky; Erin K Rottinghaus; Paul Stromberg; Joanne Turner; Gillian Beamer
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

Review 3.  Vaccine development for tuberculosis: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  A defect in the synthesis of Interferon-γ by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis.

Authors:  Mary Anne Mashruwala; Amanda K Smith; Devin R Lindsey; Margaret Moczygemba; Rick A Wetsel; John R Klein; Jeffrey K Actor; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2011-12-05       Impact factor: 3.131

5.  Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.

Authors:  Rhea N Coler; Sylvie Bertholet; Samuel O Pine; Mark T Orr; Valerie Reese; Hillarie Plessner Windish; Charles Davis; Maria Kahn; Susan L Baldwin; Steven G Reed
Journal:  J Infect Dis       Date:  2012-08-13       Impact factor: 5.226

6.  The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice.

Authors:  Arati B Kamath; Jennifer Alt; Hajer Debbabi; Chad Taylor; Samuel M Behar
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

8.  Characterization of promoter of the tuberculosis-resistant gene intracellular pathogen resistance 1.

Authors:  Yongyan Wu; Fayang Liu; Yan Zhang; Yongsheng Wang; Zekun Guo; Yong Zhang
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

9.  Man and mouse TB: contradictions and solutions.

Authors:  Alexander Apt; Igor Kramnik
Journal:  Tuberculosis (Edinb)       Date:  2009-04-02       Impact factor: 3.131

10.  Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.

Authors:  Gillian L Beamer; David K Flaherty; Bridget Vesosky; Joanne Turner
Journal:  Clin Vaccine Immunol       Date:  2008-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.